Favorable outcomes were observed among patients with vitiligo who received systemic Janus kinase inhibitors, with tofacitinib associated with the highest rate of complete resolution. Tofacitinib may ...

SCENESSE® is being evaluated as a systemic repigmentation therapy for vitiligo patients, with a clinical focus on adolescent (12 years and above) and adult patients with darker skin types (Fitzpatrick ...

An expert discusses how the lack of transparency in medication pricing creates a "black box" between actual drug costs and ...

Patients reported quality-of-life benefits from treatment for nonsegmental vitiligo, even when clinical improvement started slowly. From a clinical standpoint, vitiligo is marked by the progressive ...

Please provide your email address to receive an email when new articles are posted on . Within the baricitinib group, patients experienced a mean Vitiligo Area Scoring Index score change of 44.8% from ...